Zap Laser`s Styla MicroLaser Wins 2009 Medical Design Excellence Award

* Reuters is not responsible for the content in this press release.

Tue Apr 7, 2009 1:00pm EDT

Dentistry`s First Microlaser Honored for Revolutionary Design And Breakthrough
Technology 
PLEASANT HILL, Calif.--(Business Wire)--
Today, industry leader Zap Lasers announced that its Styla MicroLaser was
selected one of the year`s best-designed medical devices and is the winner of a
2009 Medical Design Excellence Award. Dentistry`s first microlaser, Styla boasts
a revolutionary compact and wire-free design, which was judged as one of the
year`s best by an independent, multidisciplinary panel, with expertise in
biomedical engineering, human factors, industrial design, medicine and
diagnostics before being awarded the honor. 

"The thought that a pen-sized, wire-free, portable microlaser would be
performing soft-tissue laser procedures in dentists` offices seemed unreal as
little as a year ago, but, in fact, our work on Styla began long before then,"
noted Zap Vice President Sales and Marketing Alex Di Sessa. "Styla is the result
of more than two years of precise design and engineering. Zap is honored to have
these efforts recognized by the Medical Design Excellence Awards, and proud to
have delivered a revolutionary tool that allows dental professionals to provide
their patients the highest standard of care." 

Since its introduction in May 2008, Styla has quickly become one of dentistry`s
most sought after technologies. Only 6.9 inches long and 1.9 ounces, 20 times
lighter than any other soft-tissue laser on the market today, Styla shatters
perceptions about dental lasers being cumbersome or complicated to use. Approved
by the FDA to perform more than 25 soft-tissue laser procedures, Styla`s diode
laser technology means patients require minimum anesthetic during surgery, and
experience faster healing times than traditional dentistry patients. 

In addition to eight pre-set procedures and 2.0 watts of power, Styla`s
innovative features include:

* Lightweight Aluminum Body: Tough and functional, yet lightweight and
ergonomically balanced, Styla`s main body remains comfortable in doctor`s hands,
even after extended use. 
* Disposable Tips: Ready-to-use straight from the box, Styla`s tips are
pre-threaded with fiber and use a custom-designed magnetic system to perfectly
align and secure themselves to the microlaser. 
* Intelligent Gravity Sensor: Automatically detects Styla`s orientation and
adjusts the display to be read from any angle. 
* Rechargeable Lithium Ion Batteries: Custom-engineered, one charge has enough
power for 15 procedures. Fully charged, stand-by time is more than eight hours. 
* Wireless Foot Pedal: Uses advanced wireless technology to securely communicate
with Styla.

Award-winning Styla will have the opportunity to garner more accolades on June
10, when it is honored alongside other MDEA winners at an award ceremony during
the Medical Design & Manufacturing East Conference in New York. At this event,
gold and silver MDEA award designations will be announced, noting
best-of-the-best among the MDEA honorees. 

For more information on Styla and Zap`s industry-leading family of soft-tissue
lasers visit www.zaplasers.com, or call 1-888-876-4546. 

About Zap Lasers

Based in Pleasant Hill, Calif., Zap Lasers is a dental technology company that
develops, manufactures and markets lasers and laser accessories for improved
applications and procedures in dentistry. Its line of industry-leading soft
tissue lasers includes Styla MicroLaser and StylaOrtho, the industry`s first
microlasers for soft tissue use; SoftLase Pro, widely recognized as one of the
most affordable dental diode lasers on the market; and OrthoLase, the industry`s
first diode laser specially designed for orthodontists. For more information, or
to see Zap`s complete line of dental lasers, visit www.zaplasers.com. 



KRT Marketing for Zap Lasers
Rachel Loya, 925-284-6255
rachel@krtmarketing.com



Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.